Recently, the Social Governance Innovation Conference in Huzhou has been held, at wh‍ich commendation was given to a number of enterprises identified as “¶Golden Elephant” and “Golden Bull”, major taxpayers, advanced collectives an&d individuals for key work as well as the winners of the A✔ward for Reform Breakthrough and Innovation in 2021. The talent-oriφented enterprise Orient Gene was selected as the Enterprise iden€tified as “Golden Elephant” in 2021 and won the tit§le of “Major Taxpayer”.

In recent years, in Huzhou, the "South Taihu Lake Elite Plan” has been "vigorously implemented, the cultivation of "leading figure” am₽ong talent-oriented enterprises and the “five top” crucial★ actions have been carried out in an in-depth way, promoting talent-oriented enterprises to g∞row bigger and stronger, and the contribution rate of talents to economic and social dev←elopment continuously improved. Up to now, 15 listed talent-oriented ente€rprises and 15 national dedicated, special and new “littleσ giant” talent-oriented enterprises have been cultivated in Huzhou, among which Orient Gen∑e is one of the outstanding representatives.

Extended reading

Engaged in the research and development, production and sales of in vitro♣ diagnostic products, Zhejiang Orient Gene Biological Products Co., Ltd. was liδsted on SSE STARR Market on February 5, 2020. As a listed ent↔erprise on the STAR Market of modern medical biotec★hnology, Orient Gene has a complete industrial chain layout of core ¶biological raw materials, rapid diagnostic reagents and rapid diagno€stic instruments, with hundreds of independently developed products, more than 20↓0 granted patents, and over 500 certified medical devices at home and abroad.

As a talent-oriented enterprise, established under the leadership of nat∑ional talents, Orient Gene has a R&D team made up of more than 20£0 people, including more than 80 high-level talents with master and doctoral degree o€r above, 2 persons involved in the Talent Introduction Plan of Zhejiang Province and 1 σperson involved in the National High-level Talents Special Support Program of Zhejiang→ Province. Orient Gene also owns multiple scientific research platforms such a"s Zhejiang Provincial Key Enterprise Research Institute, Zhejiang Provincial High-t♦ech Enterprise R&D Center, the academician expert≥ workstation, the postdoctoral workstation, etc., and has succe✘ssively undertaken more than 20 projects such as t≤he “Torch Program” of the Ministry of Science and Technolo>gy.

Since the outbreak of COVID-19, Orient Gene has developed 2019-nCoV test kits, and has fo∏llowed up the R & D of several differential diagnostic reagents f​or mutant strains, which were sold to more than 100 countries and regions thrβough international distributors, government procurement and± bidding in 2021.